Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 6/20 | 0.55 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.47 |
| ▸ | VNN1 | O95497 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 4/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13288837 | 0.92 | GSK3B (0.57) | GSK3BCHEK1VNN1ALDH1A1KDM4E | |
| SCHEMBL13119052 | 0.91 | GSK3B (0.68) | GSK3BCDK2CCNE1 | |
| SCHEMBL14581645 | 0.89 | GSK3B (0.51) | GSK3BCHEK1VNN1ALDH1A1CDK2 | |
| SCHEMBL13305284 | 0.88 | GSK3B (0.59) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL13304610 | 0.88 | GSK3B (0.59) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL13304611 | 0.88 | GSK3B (0.59) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL14301571 | 0.87 | GSK3B (0.53) | GSK3BCHEK1VNN1CDK2CCNE1 | |
| SCHEMBL14043165 | 0.86 | GSK3B (0.56) | GSK3BCHEK1VNN1ALDH1A1KDM4E | |
| SCHEMBL14301228 | 0.86 | GSK3B (0.53) | GSK3BCHEK1VNN1KDM4ECDK2 | |
| SCHEMBL14301565 | 0.86 | GSK3B (0.53) | GSK3BCHEK1VNN1CDK2CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008130569-A1 | NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORPORATION (US) | 2008-10-30 | — | — | WO | disclosed |